Adam Laponis, Chief Financial Officer at Twist Bioscience Corp (TWST), sold 4,000 shares at $70.00 ($280K) on 2026-05-29, disclosed to the SEC on 2026-06-02.
Scheduled sale ($280k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TWST | SELL | 2026-08-25 | $273K | — | Filing → |
| TWST | SELL | 2026-07-13 | $226K | — | Filing → |
| TWST | SELL | 2026-05-26 | $108K | — | Filing → |